Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership in Europe and Israel to Commercialize RNAi Therapeutics in additional LATAM and APAC markets including Australia
- Written by PR Newswire Asia - Asian Spectator
![]() |
- The expanded partnership will allow Alnylam and Medison to help accelerate access for patients in multiple regions under one global alliance
- Medison, the creator and leader of the multi-regional partnership category, will utilize its unique, unified platform for efficient global commercialization of Alnylam's innovative RNAi technologies
ZUG, Sw...